在阿尔及利亚的Tiaret,在狗主人中提高莱什曼病的认识和查
Taha Bia1, Houria Zait2, Carmen Sanchez3
1Laboratory of Pharmacognosy and Api-Phytothérapy (LPAP), University Abdelhamid Ibn BadisMostaganem, 27000 Mostaganem, Algeria. Faculty of Nature and Life Sciences, University Abdelhamid Ibn BadisMostaganem, 27000 Mostaganem, Algeria.
Veterinaria italiana
|April 15, 2025
概括
蒂阿雷特省的狗主人对犬类和人类内脏莱什曼病 (CVL/HVL) 显著无知. 宣传活动至关重要,以减轻与Leishmania婴儿传播相关的公共卫生风险.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
背景情况:
- 莱什曼尼亚病,特别是由莱什曼尼亚婴儿引起的莱什曼尼亚病,由于动物性传染风险,造成越来越多的公共卫生问题.
- 狗内脏莱什马尼亚症 (CVL) 是人类内脏莱什马尼亚症 (HVL) 的重要储库.
研究的目的:
- 为了评估狗主人对HVL和CVL的知识,在Tiaret省.
- 在狗主人中进行HVL的血清检测.
- 为了评估与莱什马尼亚阳性狗有关的人类感染风险.
主要方法:
- 对狗主人 (n=?) 进行了问卷调查. 关于他们对HVL和CVL的认识.
- 使用间接光抗体测试 (IFAT) 和西布洛特 (WB) 对犬主进行HVL的血清学查.
- 使用IFAT对狗进行莱什曼病的血清学查.
主要成果:
- 在狗主人中观察到对HVL和CVL知识的严重缺乏,许多人错误地识别了这些疾病.
- 血清学查显示,3%的狗主人对HVL的IFAT结果有疑问.
- 在这九个人中,他们的狗检测出Leishmania阳性,其中五个人通过Western Blot.被证实阳性HVL.
结论:
- 迫切需要针对Leishmania流行地区的狗主人开展公众宣传活动.
- 了解知识差距对于制定有效的动物传染性莱什曼病控制策略至关重要.
更多相关视频
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
22.2K
07:40Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
Published on: June 29, 2020
13.2K
相关概念视频
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:28Rabies
Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...